Quality boost for pills; Free fill for cancer candidate;

> Pill quality may get a boost from scientists at the University of Maryland, who are using near-infrared spectroscopy to study how pills dissolve in the body. Article

> Under its Fillanthropy Program, Formatech will donate services required to aseptically fill and finish one lot of ViroMed's VM206 vaccine targeting breast cancer to support upcoming clinical trials. Announcement

> Contract researcher MakroCare, in collaboration with Advanced Drug Development Services, will offer pharmacovigilance and drug safety services. Release

> Bulk drug manufacturer Unimark Remedies has plans to launch some 30 oncology and critical-care products and offer radiation, chemotherapy and oncology-specialized pharmacies under one roof. Article

> India is about to kick off its Focus Pharmacovigilance program to study a dozen "controversial drugs," including certain non-steroidal anti-inflammatories, anti-depressants and nasal decongestants, which are banned or considered risks for adverse effects by other nations. Article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.